Literature DB >> 23396042

Molecular dissection of botulinum neurotoxin reveals interdomain chaperone function.

Audrey Fischer1, Mauricio Montal.   

Abstract

Clostridium botulinum neurotoxin (BoNT) is a multi-domain protein made up of the approximately 100 kDa heavy chain (HC) and the approximately 50 kDa light chain (LC). The HC can be further subdivided into two halves: the N-terminal translocation domain (TD) and the C-terminal Receptor Binding Domain (RBD). We have investigated the minimal requirements for channel activity and LC translocation. We utilize a cellular protection assay and a single channel/single molecule LC translocation assay to characterize in real time the channel and chaperone activities of BoNT/A truncation constructs in Neuro 2A cells. The unstructured, elongated belt region of the TD is demonstrated to be dispensable for channel activity, although may be required for productive LC translocation. We show that the RBD is not necessary for channel activity or LC translocation, however it dictates the pH threshold of channel insertion into the membrane. These findings indicate that each domain functions as a chaperone for the others in addition to their individual functions, working in concert to achieve productive intoxication.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibotulinal agents; BTD; Biological weapons; BoNT; Botulism; HC; LC; LC-TD; Modular nanomachine; P(o); Protein translocase; RBD; TCEP; TD; V(½); beltless translocation domain; beta-mercaptoethanol; botulinum neurotoxin; channel open probability; heavy chain; light chain; light chain-translocation domain; pH gradient across the cis and trans compartments; receptor binding domain; single channel conductance; t(1/2); the half time for completion of translocation; the voltage at which P(o) = 0.5; translocation domain; tris-(2-carboxyethyl) phosphine; ΔpH; βME; γ

Mesh:

Substances:

Year:  2013        PMID: 23396042      PMCID: PMC3797153          DOI: 10.1016/j.toxicon.2013.01.007

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  58 in total

1.  Binding of Clostridium botulinum type C and D neurotoxins to ganglioside and phospholipid. Novel insights into the receptor for clostridial neurotoxins.

Authors:  Kentaro Tsukamoto; Tomoko Kohda; Masafumi Mukamoto; Kumiko Takeuchi; Hideshi Ihara; Masaki Saito; Shunji Kozaki
Journal:  J Biol Chem       Date:  2005-08-22       Impact factor: 5.157

2.  Structural analysis of botulinum neurotoxin serotype F light chain: implications on substrate binding and inhibitor design.

Authors:  Rakhi Agarwal; Thomas Binz; Subramanyam Swaminathan
Journal:  Biochemistry       Date:  2005-09-06       Impact factor: 3.162

3.  Crystal structure of botulinum neurotoxin type G light chain: serotype divergence in substrate recognition.

Authors:  Joseph W Arndt; Wayne Yu; Fay Bi; Raymond C Stevens
Journal:  Biochemistry       Date:  2005-07-19       Impact factor: 3.162

4.  Crystal structure of botulinum neurotoxin type A and implications for toxicity.

Authors:  D B Lacy; W Tepp; A C Cohen; B R DasGupta; R C Stevens
Journal:  Nat Struct Biol       Date:  1998-10

5.  A novel method for structure-based prediction of ion channel conductance properties.

Authors:  O S Smart; J Breed; G R Smith; M S Sansom
Journal:  Biophys J       Date:  1997-03       Impact factor: 4.033

6.  Substrate recognition strategy for botulinum neurotoxin serotype A.

Authors:  Mark A Breidenbach; Axel T Brunger
Journal:  Nature       Date:  2004-12-12       Impact factor: 49.962

7.  The high-affinity binding of Clostridium botulinum type B neurotoxin to synaptotagmin II associated with gangliosides GT1b/GD1a.

Authors:  T Nishiki; Y Tokuyama; Y Kamata; Y Nemoto; A Yoshida; K Sato; M Sekiguchi; M Takahashi; S Kozaki
Journal:  FEBS Lett       Date:  1996-01-15       Impact factor: 4.124

8.  Receptor-mediated uptake of an extracellular Bcl-x(L) fusion protein inhibits apoptosis.

Authors:  X H Liu; J C Castelli; R J Youle
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

9.  Botulinum neurotoxin type D enables cytosolic delivery of enzymatically active cargo proteins to neurones via unfolded translocation intermediates.

Authors:  Steffen Bade; Andreas Rummel; Clemens Reisinger; Tino Karnath; Gudrun Ahnert-Hilger; Hans Bigalke; Thomas Binz
Journal:  J Neurochem       Date:  2004-12       Impact factor: 5.372

10.  Sequence homology and structural analysis of the clostridial neurotoxins.

Authors:  D B Lacy; R C Stevens
Journal:  J Mol Biol       Date:  1999-09-03       Impact factor: 5.469

View more
  14 in total

Review 1.  Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology.

Authors:  Marco Pirazzini; Ornella Rossetto; Roberto Eleopra; Cesare Montecucco
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

Review 2.  The Molecular Basis of Toxins' Interactions with Intracellular Signaling via Discrete Portals.

Authors:  Adi Lahiani; Ephraim Yavin; Philip Lazarovici
Journal:  Toxins (Basel)       Date:  2017-03-16       Impact factor: 4.546

Review 3.  Cargo-delivery platforms for targeted delivery of inhibitor cargos against botulism.

Authors:  Brenda A Wilson; Mengfei Ho
Journal:  Curr Top Med Chem       Date:  2014       Impact factor: 3.295

4.  Entry of a recombinant, full-length, atoxic tetanus neurotoxin into Neuro-2a cells.

Authors:  Faith C Blum; Amanda Przedpelski; William H Tepp; Eric A Johnson; Joseph T Barbieri
Journal:  Infect Immun       Date:  2013-12-09       Impact factor: 3.441

Review 5.  Protein Toxins That Utilize Gangliosides as Host Receptors.

Authors:  Madison Zuverink; Joseph T Barbieri
Journal:  Prog Mol Biol Transl Sci       Date:  2018-03-17       Impact factor: 3.622

Review 6.  Botulinum Toxin as a Pain Killer: Players and Actions in Antinociception.

Authors:  Dong-Wan Kim; Sun-Kyung Lee; Joohong Ahnn
Journal:  Toxins (Basel)       Date:  2015-06-30       Impact factor: 4.546

Review 7.  Historical Perspectives and Guidelines for Botulinum Neurotoxin Subtype Nomenclature.

Authors:  Michael W Peck; Theresa J Smith; Fabrizio Anniballi; John W Austin; Luca Bano; Marite Bradshaw; Paula Cuervo; Luisa W Cheng; Yagmur Derman; Brigitte G Dorner; Audrey Fisher; Karen K Hill; Suzanne R Kalb; Hannu Korkeala; Miia Lindström; Florigio Lista; Carolina Lúquez; Christelle Mazuet; Marco Pirazzini; Michel R Popoff; Ornella Rossetto; Andreas Rummel; Dorothea Sesardic; Bal Ram Singh; Sandra C Stringer
Journal:  Toxins (Basel)       Date:  2017-01-18       Impact factor: 4.546

Review 8.  Toxicology and pharmacology of botulinum and tetanus neurotoxins: an update.

Authors:  Marco Pirazzini; Cesare Montecucco; Ornella Rossetto
Journal:  Arch Toxicol       Date:  2022-03-25       Impact factor: 6.168

Review 9.  Novel Botulinum Neurotoxins: Exploring Underneath the Iceberg Tip.

Authors:  Domenico Azarnia Tehran; Marco Pirazzini
Journal:  Toxins (Basel)       Date:  2018-05-10       Impact factor: 4.546

10.  Augmentation of VAMP-catalytic activity of botulinum neurotoxin serotype B does not result in increased potency in physiological systems.

Authors:  Mark Elliott; Jacquie Maignel; Sai Man Liu; Christine Favre-Guilmard; Imran Mir; Paul Farrow; Fraser Hornby; Sandra Marlin; Shilpa Palan; Matthew Beard; Johannes Krupp
Journal:  PLoS One       Date:  2017-10-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.